|
|
|
|
|
by ceejayoz
1668 days ago
|
|
> The specific targeting makes it easier to allude the vaccine as only a small part of it has to mutate. Nothing says an mRNA vaccine can't express more than one protein. That said, I'm talking more about being able to target a portion of the virus that's more fragile than others - somewhere a mutation is likely to make the virus useless if a mutation occurs there. (The ability to rapidly adjust for mutations is a bonus, too. I'm hoping we get to a regulatory regime eventually where they can tweak overnight and produce fairly locally.) > There was a study that natural immunity was more effective against the virus and variants because of this. There's information in the other direction now. https://news.yahoo.com/vaccine-confers-better-protection-tha... |
|
The way they conducted that study was terrible, read the qualifications and the limitations in the discussion at the bottom.
Personally the Israeli study looks a lot more sound.